Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 2, 2018

Total Value ($000): $135,522 (100.0% shares, 0.0% debt)

Holdings (13)

— Translate Bio 22.8%

Value ($000) $30,836 Shares 2,437,601 Est. Cost $12.65 Unrealized —

— Paratek Pharmaceuticals 19.6%

Value ($000) $26,524 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— ObsEva 11.2%

Value ($000) $15,135 Shares 999,664 Est. Cost $9.76 Unrealized —

— Kezar Life Sciences 8.9%

Value ($000) $11,994 Shares 693,272 Est. Cost $17.30 Unrealized —

SNNAQ Sienna Biopharmaceuticals 8.5%

Value ($000) $11,523 Shares 758,610 Est. Cost $21.95 Unrealized -22.7%

— FibroGen 6.0%

Value ($000) $8,178 Shares 130,646 Est. Cost $27.34 Unrealized —

— Cidara Therapeutics 5.8%

Value ($000) $7,846 Shares 1,508,794 Est. Cost $6.73 Unrealized —

— CymaBay Therapeutics 5.5%

Value ($000) $7,401 Shares 551,477 Est. Cost $4.71 Unrealized —

— ESSA Pharma 3.0%

Value ($000) $4,122 Shares 1,084,848 Est. Cost $0.58 Unrealized —

— Jounce Therapeutics 3.0%

Value ($000) $4,060 Shares 529,965 Est. Cost $21.99 Unrealized —

— Pieris Pharmaceuticals 2.9%

Value ($000) $3,946 Shares 778,230 Est. Cost $1.83 Unrealized —

— Dicerna Pharmaceuticals 2.0%

Value ($000) $2,737 Shares 223,457 Est. Cost $16.47 Unrealized —

— Egalet 0.9%

Value ($000) $1,220 Shares 2,889,926 Est. Cost $5.98 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Translate Bio	2,437,601	$30,836	22.8%	$12.65	—	Common Stock	89374L104
—	Paratek Pharmaceuticals	2,600,410	$26,524	19.6%	$34.18	—	Common Stock	699374302
—	ObsEva	999,664	$15,135	11.2%	$9.76	—	Common Stock	H5861P103
—	Kezar Life Sciences	693,272	$11,994	8.9%	$17.30	—	Common Stock	49372L100
SNNAQ	Sienna Biopharmaceuticals	758,610	$11,523	8.5%	$21.95	-22.7%	Common Stock	82622H108
—	FibroGen	130,646	$8,178	6.0%	$27.34	—	Common Stock	31572Q808
—	Cidara Therapeutics	1,508,794	$7,846	5.8%	$6.73	—	Common Stock	171757107
—	CymaBay Therapeutics	551,477	$7,401	5.5%	$4.71	—	Common Stock	23257D103
—	ESSA Pharma	1,084,848	$4,122	3.0%	$0.58	—	Common Stock	29668H104
—	Jounce Therapeutics	529,965	$4,060	3.0%	$21.99	—	Common Stock	481116101
—	Pieris Pharmaceuticals	778,230	$3,946	2.9%	$1.83	—	Common Stock	720795103
—	Dicerna Pharmaceuticals	223,457	$2,737	2.0%	$16.47	—	Common Stock	253031108
—	Egalet	2,889,926	$1,220	0.9%	$5.98	—	Common Stock	28226B104